3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
4
Phase 2
3
Phase 1/2
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Conditions
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Cyclophosphamide
21
fludarabine
12
Rituximab
10
Vincristine
6
Etoposide
6
Prednisone
5
Doxorubicin
5
pembrolizumab
4
Radiotherapy
4
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Immunotherapy, Adoptive
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Dexamethasone
4
venetoclax
3
ibrutinib
3
Nivolumab
3
Imiquimod
3
Ifosfamide
3
Exercise
3
Biopsy
3
68Ga-pentixafor
3
fludarabine phosphate
2
daratumumab
2
Transplantation
2
Stem Cell Transplantation
2
Specimen Handling
2
Sirolimus
2
Roflumilast
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Valproic Acid
×
Lymphoid
×
Clear all
NCT02144623
2017-03-03
PREVAIL
Lund University Hospital
Phase EARLY_PHASE1
Completed
4 enrolled